Medicine and Dentistry
Sulforaphane
100%
Ligation
58%
Carotid Artery Ligation
50%
Isothiocyanic Acid
50%
Ventricular Hypertrophy
50%
Brain Ischemia
50%
Infarction
50%
End Organ Damage
50%
Calcitonin Gene Related Peptide
50%
Heart Failure
50%
Cell Proliferation
50%
Vascular Smooth Muscle Cell
50%
Supplementation
50%
Regulatory Mechanism
50%
Metabolic Stress
50%
Hypoxia
50%
Hypertension
41%
Therapeutic Procedure
32%
Angiotensin II
25%
Oxygen
25%
Blood Vessel Injury
16%
Aptitude
16%
Heart Ventricle Remodeling
16%
Western Blot
16%
Cardiovascular Disease
16%
Enalapril Maleate
15%
Incidence
14%
Heart Injury
8%
Antihypertensive Agent
8%
Fibrosis
8%
Heart Function
8%
Gene Induction
8%
Skin
8%
Desensitization
8%
Behavioral Change
8%
Biological Marker
8%
Echocardiography
8%
Peptide
8%
Angiogenesis
8%
Cell Survival
8%
Blood Pressure
8%
Serositis
8%
Ex Vivo
8%
Analysis
8%
Programmed Cell Death
8%
Heart Disease
8%
Oxidative Stress
8%
Aortic Constriction
8%
RNA Analysis
8%
Histology
8%
Neuroscience
Ischemia
100%
Sulforaphane
83%
Stroke
57%
Reperfusion Injury
50%
Ischemic Stroke
23%
Transcription Factor Nrf2
23%
Microglia
16%
Angiogenesis
16%
Cresyl Violet
16%
Middle Cerebral Artery
16%
Endothelium
16%
Peroxisome Proliferator-Activated Receptor
16%
Brain
16%
Neurogenesis
16%
Ion Transport
7%
Free Radicals
7%
Skull
7%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
50%
Heart Ventricle Hypertrophy
50%
Experimental Hypertension
50%
Calcitonin Gene Related Peptide
50%
Hypertension
41%
Angiotensin II
25%
Heart Ventricle Remodeling
16%
Cardiovascular Disease
16%
Blood Vessel Injury
8%
Desensitization
8%
Inflammation
8%
Calcitonin Gene Related Peptide Receptor Antagonist
8%
Heart Disease
8%
Apoptosis
8%
Antihypertensive Agent
8%
Hypertrophy
8%
Aortic Constriction
8%
Biological Marker
8%
RNA
8%
Fibrosis
8%
Survival
8%
Heart Injury
8%
Peptide
8%
